TCH (docetaxel, carboplatin, trastuzumab)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for TCH (docetaxel, carboplatin, trastuzumab), covering 2020-07-28 to 2020-07-28. Get the full timeline:
Most recent: Clinical Trial Update: TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer [Phase 2]